The chase for the next breakout stock is as old as the markets themselves. Every investor dreams of catching a “ground floor” opportunity—the kind where a few cents can turn into dollars. That dream often leads straight to the wild world of penny stocks: companies trading under $5, with big ambitions but uncertain futures.
The upside? Life-changing returns. The downside? Extreme volatility, thin trading volumes, and a history of shady schemes. In this post, we look at three sub-dollar stocks making waves right now: Greene Concepts (INKW), BioNxt Solutions (BNXTF), and Thunder Power Holdings (AIEV).
Greene Concepts (INKW): Bottled Water, Big Dreams
Greene Concepts is carving out a niche in the booming bottled water industry with its BE WATER™ brand. Unlike competitors that filter tap water, Greene sources its product from a natural spring in North Carolina, tapping into consumer demand for authenticity and eco-consciousness.
The company has already landed distribution with Walmart and Camping World, and is pushing toward nationwide expansion. Beyond retail, it’s exploring white-label manufacturing and even water supply solutions for drought-stricken regions abroad.
Key Snapshot:
- Ticker: INKW
- Price: $0.0006
- Market Cap: ~$1.5M
- Assets: $5.6M+
- Moves: Cancelled $314K in convertible debt; up-listed to OTCID
The bullish case? The stock trades at a fraction of its asset value, hinting at undervaluation. The bearish view? Competing with giants like Nestlé will be an uphill climb.
BioNxt Solutions (BNXTF): The Biotech Gambit
If Greene Concepts sells water, BioNxt sells science. This clinical-stage biotech is developing next-gen drug delivery platforms—think thin films, patches, and targeted therapies.
The crown jewel? An oral dissolvable film for Semaglutide, the blockbuster ingredient in Ozempic. Instead of injections or tablets, BioNxt’s version could make treatment easier and more accessible.
Key Snapshot:
- Ticker: BNXTF
- Price: $0.63
- Focus: Neurology, oncology, immunology
- Moves: Completed proof-of-concept for Semaglutide film; up-listed to OTCQB
The company is still early in development, but its up-listing shows commitment to transparency. If its tech pans out, BioNxt could tap into a market worth billions.
Thunder Power Holdings (AIEV): A Desperate Pivot
Thunder Power was once an electric vehicle dreamer. Today, it’s trying to pivot into clean energy by acquiring solar power plants in Taiwan. The problem? Its financials don’t add up.
Key Snapshot:
- Ticker: AIEV
- Price: $0.05
- Cash: Just $97K
- Trouble: No revenue, Nasdaq delisting, “going concern” warning
The company talks big about acquisitions, but with virtually no money in the bank, it’s hard to see how it survives—let alone executes a pivot. For many investors, this looks more like a cautionary tale than a comeback story.
The Reality Check on Penny Stocks
Investing in microcaps is a thrill ride. The potential for 10x returns is real—but so is the risk of losing it all. Here’s why caution is critical:
- Transparency Gaps: Many penny stocks lack reliable disclosures.
- Liquidity Traps: Low trading volume can leave you stuck in a bad trade.
- Pump-and-Dump Schemes: Classic fraud still thrives in this space.
The truth? The “ground floor” can look like a golden opportunity but easily collapse into a trapdoor.
Final Word
Greene Concepts shows promise with undervalued assets and smart debt moves. BioNxt offers biotech excitement with disruptive potential. Thunder Power, on the other hand, highlights the dangers of betting on distressed companies.
In the world of penny stocks, the only guarantee is volatility. Do your homework, question the hype, and never invest more than you can afford to lose.
Disclosure: Lusso’s News, LLC (“EMV”) has been compensated by Greene Concepts, Inc. (“Greene Concepts”) in the amount of $5,000 USD per month, commencing August 13, 2025, and continuing through September 31, 2025, with the possibility of extension until further notice. This compensation is for the creation and dissemination of content about Greene Concepts (OTC: INKW), including but not limited to articles, website postings, social media updates, and other promotional materials. The content produced by EMV is intended solely for informational purposes. It does not constitute an offer to sell, a solicitation to buy, or a recommendation regarding any security, investment product, or trading strategy. EMV is not a registered investment adviser or broker-dealer, and nothing in this content should be construed as personalized investment advice. Investing in securities involves risks, including the potential loss of principal. Readers should conduct their own independent research, perform due diligence, and consult with a licensed financial adviser, attorney, or tax professional before making any investment decisions. EMV’s compensation from Greene Concepts presents a conflict of interest as EMV has a financial incentive to promote Greene Concepts. As a result, the content may be biased and should not be relied upon as independent or impartial. By accessing this content or the associated website, you acknowledge and agree to the terms of this disclaimer.
